Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileLorelei Ann Mucci, SC.D.

TitleAssociate Professor of Epidemiology
InstitutionHarvard T.H. Chan School of Public Health
DepartmentEpidemiology
AddressHarvard School of Public Health
Kresge Bldg, 9th Floor
677 Huntington Ave
Boston MA 02115
Phone617/432-1732
Fax617/566-7805
vCardDownload vCard (login for email)
Profile Picture
Other Positions
TitleAssistant Professor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine


Collapse Mentoring 
Collapse completed student projects
The effect of SRD5a1/2 genetic variants on the TMPRSS2:ERG fusion in prostate cancer progression
Summer, 06/15/09 - 08/14/09
The Implications of TMPRSS2:ERG Fusion Status In Prostate Cancer
Summer, 07/01/15 - 04/01/16

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R01CA202690     (MUCCI, LORELEI)Jan 20, 2016 - Dec 31, 2019
NIH/NCI
Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort
Role: Principal Investigator

U01CA167552     (WILLETT, WALTER C.)Aug 21, 2012 - Jul 31, 2022
NIH/NCI
Cancer Epidemiology Cohort in Male Health Professionals
Role: Co-Principal Investigator

R01CA136578     (MUCCI, LORELEI)Mar 3, 2009 - Jan 31, 2015
NIH/NCI
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
Role: Principal Investigator

P50CA090381     (LODA, MASSIMO)Apr 1, 2001 - Jun 30, 2018
NIH/NCI
DF/HCC SPORE in Prostate Cancer
Role: Co-Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Sheill G, Brady L, Guinan E, Hayes B, Casey O, Greene J, Vlajnic T, Cahill F, Van Hemelrijck M, Peat N, Rudman S, Hussey J, Cunningham M, Grogan L, Lynch T, Manecksha RP, McCaffrey J, Mucci L, Sheils O, O'Leary J, O'Donnell DM, McDermott R, Finn S. The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial. Trials. 2017 Oct 04; 18(1):456. PMID: 28978344.
    View in: PubMed
  2. Lu D, Carlsson J, Penney KL, Davidsson S, Andersson SO, Mucci LA, Valdimarsdóttir U, Andrén O, Fang F, Fall K. Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease. Cancer Epidemiol Biomarkers Prev. 2017 Sep 22. PMID: 28939587.
    View in: PubMed
  3. Mucci LA, Kantoff PW. Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer? J Clin Oncol. 2017 Oct 10; 35(29):3272-3274. PMID: 28817369.
    View in: PubMed
  4. Stopsack KH, Gerke TA, Andrén O, Andersson SO, Giovannucci EL, Mucci LA, Rider JR. Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Carcinogenesis. 2017 08 01; 38(8):806-811. PMID: 28595267.
    View in: PubMed
  5. Harshman LC, Werner L, Tripathi A, Wang X, Maughan BL, Antonarakis ES, Nakabayashi M, McKay R, Pomerantz M, Mucci LA, Taplin ME, Sweeney CJ, Lee GM, Kantoff PW. The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer. Prostate. 2017 May; 77(13):1303-1311. PMID: 28762529.
    View in: PubMed
  6. Kurushima Y, Silventoinen K, Dokkedal U, Skytthe A, Mucci LA, Christensen K, Hjelmborg JVB. Heritability of the Number of Teeth in Middle-Aged and Older Danish Twins. J Dent Res. 2017 Aug 01; 22034517724782. PMID: 28787219.
    View in: PubMed
  7. Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, Ellipse Consortium T, Amos CI, Bezieau S, Bickeböller H, Brenner H, Brennan P, Chang-Claude J, Conti DV, Doherty JA, Gruber SB, Harrison TA, Hayes RB, Hoffmeister M, Houlston RS, Hung RJ, Jenkins MA, Kraft P, Lawrenson K, McKay J, Markt S, Mucci L, Phelan CM, Qu C, Risch A, Rossing MA, Wichmann HE, Shi J, Schernhammer E, Yu K, Landi MT, Caporaso NE. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. Int J Cancer. 2017 Nov 01; 141(9):1794-1802. PMID: 28699174.
    View in: PubMed
  8. Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center. Gastroenterology. 2017 Nov; 153(5):1284-1294.e1. PMID: 28739282.
    View in: PubMed
  9. Ebot EM, Gerke T, Labbé DP, Sinnott JA, Zadra G, Rider JR, Tyekucheva S, Wilson KM, Kelly RS, Shui IM, Loda M, Kantoff PW, Finn S, Vander Heiden MG, Brown M, Giovannucci EL, Mucci LA. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. Cancer. 2017 Nov 01; 123(21):4130-4138. PMID: 28700821.
    View in: PubMed
  10. Markt SC, Mucci LA. Authors' reply to Rishniw. BMJ. 2017 Jun 16; 357:j2910. PMID: 28623236.
    View in: PubMed
  11. Dickerman BA, Ahearn TU, Giovannucci E, Stampfer MJ, Nguyen PL, Mucci LA, Wilson KM. Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer. Int J Cancer. 2017 Sep 01; 141(5):933-944. PMID: 28543830.
    View in: PubMed
  12. Pernar CH, Fall K, Rider JR, Markt SC, Adami HO, Andersson SO, Valdimarsdottir U, Andrén O, Mucci LA. A Walking Intervention Among Men With Prostate Cancer: A Pilot Study. Clin Genitourin Cancer. 2017 May 31. PMID: 28668276.
    View in: PubMed
  13. Mucci LA, Pernar CH, Peisch S, Gerke T, Wilson KM. Prostate cancer incidence as an iceberg. Eur J Epidemiol. 2017 May 30. PMID: 28560536.
    View in: PubMed
  14. Downer MK, Batista JL, Mucci LA, Stampfer MJ, Epstein MM, Håkansson N, Wolk A, Johansson JE, Andrén O, Fall K, Andersson SO. Dairy intake in relation to prostate cancer survival. Int J Cancer. 2017 May 01; 140(9):2060-2069. PMID: 28187509.
    View in: PubMed
  15. Tsianakas V, Harris J, Ream E, Van Hemelrijck M, Purushotham A, Mucci L, Green JS, Fewster J, Armes J. CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer. BMJ Open. 2017 Feb 15; 7(2):e013719. PMID: 28202500.
    View in: PubMed
  16. Downer MK, Allard CB, Preston MA, Gaziano JM, Stampfer MJ, Mucci LA, Batista JL. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study. Eur Urol. 2017 Nov; 72(5):821-827. PMID: 28189429.
    View in: PubMed
  17. Pettersson A, Gerke T, Fall K, Pawitan Y, Holmberg L, Giovannucci EL, Kantoff PW, Adami HO, Rider JR, Mucci LA. The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies. Cancer. 2017 May 01; 123(9):1490-1496. PMID: 28152172.
    View in: PubMed
  18. Graff RE, Möller S, Passarelli MN, Witte JS, Skytthe A, Christensen K, Tan Q, Adami HO, Czene K, Harris JR, Pukkala E, Kaprio J, Giovannucci EL, Mucci LA, Hjelmborg JB. Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1256-1264. PMID: 28130150.
    View in: PubMed
  19. Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG. Prostate. 2017 May; 77(6):647-653. PMID: 28102015.
    View in: PubMed
  20. Fankhauser CD, Mucci LA, Gerke TA. Re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol 2017;71:907-12. Eur Urol. 2017 Jul; 72(1):e9-e10. PMID: 28108146.
    View in: PubMed
  21. Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA. Perineural Invasion and Risk of Lethal Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2017 May; 26(5):719-726. PMID: 28062398.
    View in: PubMed
  22. Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, Adami HO, Stattin P, Nyrén O, Mucci LA. Snus use, smoking and survival among prostate cancer patients. Int J Cancer. 2016 Dec 15; 139(12):2753-2759. PMID: 27582277.
    View in: PubMed
  23. Markt SC, Nuttall E, Turman C, Sinnott J, Rimm EB, Ecsedy E, Unger RH, Fall K, Finn S, Jensen MK, Rider JR, Kraft P, Mucci LA. Sniffing out significant "Pee values": genome wide association study of asparagus anosmia. BMJ. 2016 Dec 13; 355:i6071. PMID: 27965198.
    View in: PubMed
  24. Kelly RS, Sinnott JA, Rider JR, Ebot EM, Gerke T, Bowden M, Pettersson A, Loda M, Sesso HD, Kantoff PW, Martin NE, Giovannucci EL, Tyekucheva S, Heiden MV, Mucci LA. The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study. Cancer Metab. 2016; 4:22. PMID: 27980733.
    View in: PubMed
  25. Hjelmborg J, Korhonen T, Holst K, Skytthe A, Pukkala E, Kutschke J, Harris JR, Mucci LA, Christensen K, Czene K, Adami HO, Scheike T, Kaprio J. Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer. Thorax. 2017 Nov; 72(11):1021-1027. PMID: 29054888.
    View in: PubMed
  26. Dickerman BA, Markt SC, Koskenvuo M, Hublin C, Pukkala E, Mucci LA, Kaprio J. Sleep disruption, chronotype, shift work, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins. Cancer Causes Control. 2016 Nov; 27(11):1361-1370. PMID: 27734240.
    View in: PubMed
  27. Haraldsdottir A, Steingrimsdottir L, Valdimarsdottir UA, Aspelund T, Tryggvadottir L, Harris TB, Launer LJ, Mucci LA, Giovannucci EL, Adami HO, Gudnason V, Torfadottir JE. Early Life Residence, Fish Consumption, and Risk of Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2017 Mar; 26(3):346-354. PMID: 27765796.
    View in: PubMed
  28. Sinnott JA, Peisch SF, Tyekucheva S, Gerke T, Lis R, Rider JR, Fiorentino M, Stampfer MJ, Mucci LA, Loda M, Penney KL. Prognostic Utility of a New mRNA Expression Signature of Gleason Score. Clin Cancer Res. 2017 Jan 01; 23(1):81-87. PMID: 27663590.
    View in: PubMed
  29. Wilson KM, Mucci LA, Drake BF, Preston MA, Stampfer MJ, Giovannucci E, Kibel AS. Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression. Cancer Prev Res (Phila). 2016 Dec; 9(12):933-941. PMID: 27651069.
    View in: PubMed
  30. Stopsack KH, Greenberg AJ, Mucci LA. Common medications and prostate cancer mortality: a review. World J Urol. 2017 Jun; 35(6):875-882. PMID: 27492013.
    View in: PubMed
  31. Sigurdardottir LG, Markt SC, Sigurdsson S, Aspelund T, Fall K, Schernhammer E, Rider JR, Launer L, Harris T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men. J Biol Rhythms. 2016 Oct; 31(5):461-9. PMID: 27449477.
    View in: PubMed
  32. Pernar CH, Markt SC, McKay RR, Mucci LA. CHALLENGE Trial 1 Year Feasibility Results-Letter. Cancer Epidemiol Biomarkers Prev. 2016 08; 25(8):1277. PMID: 27418272; PMCID: PMC4970942 [Available on 08/01/17].
  33. Russnes KM, Möller E, Wilson KM, Carlsen M, Blomhoff R, Smeland S, Adami HO, Grönberg H, Mucci LA, Bälter K. Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study. BMC Cancer. 2016 Jul 11; 16:438. PMID: 27400803; PMCID: PMC4939657.
  34. Yang M, Zu K, Mucci LA, Rider JR, Fiorentino M, Clinton SK, Loda M, Stampfer MJ, Giovannucci E. Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade. Cancer Causes Control. 2016 Aug; 27(8):1043-7. PMID: 27379990; PMCID: PMC4958547 [Available on 08/01/17].
  35. Dickerman BA, Markt SC, Koskenvuo M, Pukkala E, Mucci LA, Kaprio J. Alcohol intake, drinking patterns, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins. Cancer Causes Control. 2016 Sep; 27(9):1049-58. PMID: 27351919.
    View in: PubMed
  36. Stopsack KH, Gerke TA, Sinnott JA, Penney KL, Tyekucheva S, Sesso HD, Andersson SO, Andrén O, Cerhan JR, Giovannucci EL, Mucci LA, Rider JR. Cholesterol Metabolism and Prostate Cancer Lethality. Cancer Res. 2016 Aug 15; 76(16):4785-90. PMID: 27325648; PMCID: PMC4987257 [Available on 08/15/17].
  37. Rider JR, Wilson KM, Mucci LA, Giovannucci EL. Reply to Cédric Annweiler, Pierre Bigot, and Spyridon N. Karras' Letter to the Editor re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974-82. Eur Urol. 2017 Jan; 71(1):e18. PMID: 27317088.
    View in: PubMed
  38. Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ, Mucci LA. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016 Aug 10; 34(23):2705-11. PMID: 27298404; PMCID: PMC5019757 [Available on 08/10/17].
  39. Chan JM, Darke AK, Penney KL, Tangen CM, Goodman PJ, Lee GM, Sun T, Peisch S, Tinianow AM, Rae JM, Klein EA, Thompson IM, Kantoff PW, Mucci LA. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT. Cancer Epidemiol Biomarkers Prev. 2016 07; 25(7):1050-1058. PMID: 27197287.
    View in: PubMed
  40. Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Reply to Herney Andrés García-Perdomo and Ramiro Manzano Nunez's Letter to the Editor Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer M. Sinnott, Rachel S. Kelly, Lorelei A. Mucci, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974-82: Looking Deeper: P-hacking and Some Other Bias. Eur Urol. 2016 Dec; 70(6):e156-e157. PMID: 27156131.
    View in: PubMed
  41. Ahearn TU, Tchrakian N, Wilson KM, Lis R, Nuttall E, Sesso HD, Loda M, Giovannucci E, Mucci LA, Finn S, Shui IM. Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression. J Clin Endocrinol Metab. 2016 Jun; 101(6):2520-7. PMID: 27115058; PMCID: PMC4891799 [Available on 06/01/17].
  42. Börnigen D, Tyekucheva S, Wang X, Rider JR, Lee GS, Mucci LA, Sweeney C, Huttenhower C. Computational Reconstruction of NF?B Pathway Interaction Mechanisms during Prostate Cancer. PLoS Comput Biol. 2016 Apr; 12(4):e1004820. PMID: 27078000; PMCID: PMC4831844.
  43. Kelly RS, Vander Heiden MG, Giovannucci E, Mucci LA. Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence. Cancer Epidemiol Biomarkers Prev. 2016 06; 25(6):887-906. PMID: 27197278; PMCID: PMC4891222 [Available on 06/01/17].
  44. Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol. 2016 Dec; 70(6):974-982. PMID: 27033442.
    View in: PubMed
  45. Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression. Br J Cancer. 2016 Apr 12; 114(8):939-44. PMID: 26986253; PMCID: PMC4984801 [Available on 04/12/17].
  46. Rudman SM, Gray KP, Batista JL, Pitt MJ, Giovannucci EL, Harper PG, Loda M, Mucci LA, Sweeney CJ. Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence. BJU Int. 2016 Dec; 118(6):919-926. PMID: 26805930.
    View in: PubMed
  47. Penney KL, Pettersson A, Shui IM, Graff RE, Kraft P, Lis RT, Sesso HD, Loda M, Mucci LA. Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes. Cancer Epidemiol Biomarkers Prev. 2016 05; 25(5):745-9. PMID: 26941365; PMCID: PMC4873420 [Available on 05/01/17].
  48. Sanchez A, Schoenfeld JD, Nguyen PL, Fiorentino M, Chowdhury D, Stampfer MJ, Sesso HD, Giovannucci E, Mucci LA, Shui IM. Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment. Prostate Cancer Prostatic Dis. 2016 06; 19(2):197-201. PMID: 26926928; PMCID: PMC4865401 [Available on 12/01/16].
  49. Linn DE, Penney KL, Bronson RT, Mucci LA, Li Z. Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression. Cancer Res. 2016 04 01; 76(7):1869-81. PMID: 26880803; PMCID: PMC4873435 [Available on 04/01/17].
  50. Xie W, Yang M, Chan J, Sun T, Mucci LA, Penney KL, Lee GS, Kantoff PW. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis. Prostate. 2016 May; 76(7):691-9. PMID: 26847995.
    View in: PubMed
  51. Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr. 2016 Mar; 103(3):851-60. PMID: 26817504; PMCID: PMC4763492 [Available on 03/01/17].
  52. Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA. Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort. Carcinogenesis. 2016 Mar; 37(3):262-8. PMID: 26775038.
    View in: PubMed
  53. Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, Möller S, Unger RH, McIntosh C, Nuttall E, Brandt I, Penney KL, Hartman M, Kraft P, Parmigiani G, Christensen K, Koskenvuo M, Holm NV, Heikkilä K, Pukkala E, Skytthe A, Adami HO, Kaprio J. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA. 2016 Jan 05; 315(1):68-76. PMID: 26746459.
    View in: PubMed
  54. Mehra R, Udager AM, Ahearn TU, Cao X, Feng FY, Loda M, Petimar JS, Kantoff P, Mucci LA, Chinnaiyan AM. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer. Eur Urol. 2016 Oct; 70(4):549-552. PMID: 26724257.
    View in: PubMed
  55. Markt SC, Flynn-Evans EE, Valdimarsdottir UA, Sigurdardottir LG, Tamimi RM, Batista JL, Haneuse S, Lockley SW, Stampfer M, Wilson KM, Czeisler CA, Rider JR, Mucci LA. Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):302-8. PMID: 26677208; PMCID: PMC4767658 [Available on 02/01/17].
  56. Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst. 2016 Feb; 108(2). PMID: 26615022; PMCID: PMC4862436 [Available on 02/01/17].
  57. Möller S, Mucci LA, Harris JR, Scheike T, Holst K, Halekoh U, Adami HO, Czene K, Christensen K, Holm NV, Pukkala E, Skytthe A, Kaprio J, Hjelmborg JB. The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):145-50. PMID: 26554920.
    View in: PubMed
  58. Lu D, Sinnott JA, Valdimarsdóttir U, Fang F, Gerke T, Tyekucheva S, Fiorentino M, Lambe M, Sesso HD, Sweeney CJ, Wilson KM, Giovannucci EL, Loda M, Mucci LA, Fall K. Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer. Clin Cancer Res. 2016 Feb 01; 22(3):765-772. PMID: 26490316; PMCID: PMC4738177 [Available on 02/01/17].
  59. Hurley PJ, Sundi D, Shinder B, Simons BW, Hughes RM, Miller RM, Benzon B, Faraj SF, Netto GJ, Vergara IA, Erho N, Davicioni E, Karnes RJ, Yan G, Ewing C, Isaacs SD, Berman DM, Rider JR, Jordahl KM, Mucci LA, Huang J, An SS, Park BH, Isaacs WB, Marchionni L, Ross AE, Schaeffer EM. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res. 2016 Jan 15; 22(2):448-58. PMID: 26446945; PMCID: PMC4715968 [Available on 01/15/17].
  60. Binder M, Shui IM, Wilson KM, Penney KL, Mucci LA, Kibel AS. Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer. Cancer Causes Control. 2015 Dec; 26(12):1751-9. PMID: 26407952; PMCID: PMC4633306 [Available on 12/01/16].
  61. Möller E, Wilson KM, Batista JL, Mucci LA, Bälter K, Giovannucci E. Body size across the life course and prostate cancer in the Health Professionals Follow-up Study. Int J Cancer. 2016 Feb 15; 138(4):853-65. PMID: 26355806.
    View in: PubMed
  62. Gerke TA, Martin NE, Ding Z, Nuttall EJ, Stack EC, Giovannucci E, Lis RT, Stampfer MJ, Kantoff PW, Parmigiani G, Loda M, Mucci LA. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC. Prostate. 2015 Dec; 75(16):1926-33. PMID: 26469352; PMCID: PMC4831584 [Available on 12/01/16].
  63. Markt SC, Grotta A, Nyren O, Adami HO, Mucci LA, Valdimarsdottir UA, Stattin P, Bellocco R, Lagerros YT. Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort. Sleep. 2015 Sep 01; 38(9):1405-10. PMID: 26118562; PMCID: PMC4531408.
  64. Ahrenfeldt LJ, Skytthe A, Möller S, Czene K, Adami HO, Mucci LA, Kaprio J, Petersen I, Christensen K, Lindahl-Jacobsen R. Risk of Sex-Specific Cancers in Opposite-Sex and Same-Sex Twins in Denmark and Sweden. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1622-8. PMID: 26282631; PMCID: PMC4782008.
  65. Van Blarigan EL, Gerstenberger JP, Kenfield SA, Giovannucci EL, Stampfer MJ, Jones LW, Clinton SK, Chan JM, Mucci LA. Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study. Cancer Prev Res (Phila). 2015 Oct; 8(10):962-967. PMID: 26276753; PMCID: PMC4596787 [Available on 10/01/16].
  66. Markt SC, Shui IM, Unger RH, Urun Y, Berg CD, Black A, Brennan P, Bueno-de-Mesquita HB, Gapstur SM, Giovannucci E, Haiman C, Henderson B, Hoover RN, Hunter DJ, Key TJ, Khaw KT, Canzian F, Larranga N, Le Marchand L, Ma J, Naccarati A, Siddiq A, Stampfer MJ, Stattin P, Stevens VL, Stram DO, Tjønneland A, Travis RC, Trichopoulos D, Ziegler RG, Lindstrom S, Kraft P, Mucci LA, Choueiri TK, Wilson KM. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3). Prostate. 2015 Nov; 75(15):1677-81. PMID: 26268879; PMCID: PMC4578997 [Available on 11/01/16].
  67. Sutcliffe S, Alderete JF, Neace C, Joyce PA, Gaydos CA, Huth JI, Mucci LA, Signorello LB. Persistence of Trichomonas vaginalis serostatus in men over time. Cancer Causes Control. 2015 Oct; 26(10):1461-6. PMID: 26223890; PMCID: PMC4567958 [Available on 10/01/16].
  68. Liu H, Shui IM, Platz EA, Mucci LA, Giovannucci EL. No Association of ApoE Genotype with Risk of Prostate Cancer: A Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1632-4. PMID: 26189769; PMCID: PMC4743244 [Available on 10/01/16].
  69. Hrafnkelsdóttir SM, Torfadóttir JE, Aspelund T, Magnusson KT, Tryggvadóttir L, Gudnason V, Mucci LA, Stampfer M, Valdimarsdóttir UA. Physical Activity from Early Adulthood and Risk of Prostate Cancer: A 24-Year Follow-Up Study among Icelandic Men. Cancer Prev Res (Phila). 2015 Oct; 8(10):905-11. PMID: 26152935.
    View in: PubMed
  70. Harshman LC, Wang X, Nakabayashi M, Xie W, Valenca L, Werner L, Yu Y, Kantoff AM, Sweeney CJ, Mucci LA, Pomerantz M, Lee GS, Kantoff PW. Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer. JAMA Oncol. 2015 Jul; 1(4):495-504. PMID: 26181260.
    View in: PubMed
  71. Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson SO, Johansson JE, Fiorentino M, Finn S, Fedele G, Stampfer M, Kantoff PW, Mucci LA, Loda M. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Mol Cancer Res. 2015 Oct; 13(10):1431-40. PMID: 26124442; PMCID: PMC4618038 [Available on 10/01/16].
  72. Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, Presti J, Wang Z, Berndt SI, Chanock SJ, McDonnell SK, French AJ, Schaid DJ, Thibodeau SN, Li Q, Freedman ML, Penney KL, Mucci LA, Haiman CA, Henderson BE, Seminara D, Kvale MN, Kwok PY, Schaefer C, Risch N, Witte JS. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91. PMID: 26034056; PMCID: PMC4527942.
  73. Kantor ED, Lipworth L, Fowke JH, Giovannucci EL, Mucci LA, Signorello LB. Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study. Prostate. 2015 Sep; 75(13):1384-93. PMID: 26012482; PMCID: PMC4536142.
  74. Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Van Blarigan EL, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells. Cancer Prev Res (Phila). 2015 Aug; 8(8):737-42. PMID: 25990087; PMCID: PMC4526348 [Available on 08/01/16].
  75. Bourke L, Boorjian SA, Briganti A, Klotz L, Mucci L, Resnick MJ, Rosario DJ, Skolarus TA, Penson DF. Survivorship and improving quality of life in men with prostate cancer. Eur Urol. 2015 Sep; 68(3):374-83. PMID: 25941049.
    View in: PubMed
  76. Tyekucheva S, Martin NE, Stack EC, Wei W, Vathipadiekal V, Waldron L, Fiorentino M, Lis RT, Stampfer MJ, Loda M, Parmigiani G, Mucci LA, Birrer M. Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues. J Mol Diagn. 2015 Jul; 17(4):374-81. PMID: 25937617; PMCID: PMC4483460.
  77. Sinnott JA, Rider JR, Carlsson J, Gerke T, Tyekucheva S, Penney KL, Sesso HD, Loda M, Fall K, Stampfer MJ, Mucci LA, Pawitan Y, Andersson SO, Andrén O. Molecular differences in transition zone and peripheral zone prostate tumors. Carcinogenesis. 2015 Jun; 36(6):632-8. PMID: 25870172; PMCID: PMC4572920.
  78. Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, Giovannucci EL, Loda M, Mucci LA, Finn S. Tumor expression of adiponectin receptor 2 and lethal prostate cancer. Carcinogenesis. 2015 Jun; 36(6):639-47. PMID: 25863129; PMCID: PMC4481603.
  79. Gerdtsson A, Poon JB, Thorek DL, Mucci LA, Evans MJ, Scardino P, Abrahamsson PA, Nilsson P, Manjer J, Bjartell A, Malm J, Vickers A, Freedland SJ, Lilja H, Ulmert D. Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death. Eur Urol. 2015 Dec; 68(6):1076-82. PMID: 25794458; PMCID: PMC4573834.
  80. Harris J, Tsianakas V, Ream E, Van Hemelrijck M, Purushotham A, Mucci L, Green JS, Robb K, Fewster J, Armes J. CanWalk: study protocol for a randomized feasibility trial of a walking intervention for people with recurrent or metastatic cancer. Pilot Feasibility Stud. 2015; 1:7. PMID: 27965787.
    View in: PubMed
  81. Shui IM, Mondul AM, Lindström S, Tsilidis KK, Travis RC, Gerke T, Albanes D, Mucci LA, Giovannucci E, Kraft P. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer. 2015 Jun 15; 121(12):1949-56. PMID: 25731953; PMCID: PMC4457645.
  82. Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, Rider JR, Fiorentino M, Sesso HD, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Nguyen PL, Sweeney CJ, Mucci LA. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Prostate. 2015 Jun 15; 75(9):897-906. PMID: 25728532; PMCID: PMC4424159 [Available on 06/01/16].
  83. Mucci LA, Hunter DJ, Williams M. Dimitrios Trichopoulos: in memoriam (1938-2014). Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):483. PMID: 25750250.
    View in: PubMed
  84. Platz EA, Drake CG, Wilson KM, Sutcliffe S, Kenfield SA, Mucci LA, Stampfer MJ, Willett WC, Camargo CA, Giovannucci E. Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study. Int J Cancer. 2015 Aug 15; 137(4):949-58. PMID: 25648070; PMCID: PMC4478199.
  85. Mucci LA, Siddiqui MM, Wilson KM, Giovannucci EL. Reply to D.C. Sokal et al. J Clin Oncol. 2015 Feb 20; 33(6):670-1. PMID: 25605836.
    View in: PubMed
  86. Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan JM, Kantoff PW, Stampfer MJ, Nguyen PL, Mucci LA. GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis. Clin Genitourin Cancer. 2015 Aug; 13(4):370-377.e1. PMID: 25662905; PMCID: PMC5038132.
  87. Labbé DP, Zadra G, Ebot EM, Mucci LA, Kantoff PW, Loda M, Brown M. Role of diet in prostate cancer: the epigenetic link. Oncogene. 2015 Sep 03; 34(36):4683-91. PMID: 25531313; PMCID: PMC4476943 [Available on 03/03/16].
  88. Wilson KM, Shui IM, Mucci LA, Giovannucci E. Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study. Am J Clin Nutr. 2015 Jan; 101(1):173-83. PMID: 25527761; PMCID: PMC4266887.
  89. Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, Rider JR, Tamimi RM, Batista JL, Haneuse S, Flynn-Evans E, Lockley SW, Czeisler CA, Stampfer MJ, Launer L, Harris T, Smith AV, Gudnason V, Lindstrom S, Kraft P, Mucci LA. Circadian clock genes and risk of fatal prostate cancer. Cancer Causes Control. 2015 Jan; 26(1):25-33. PMID: 25388799; PMCID: PMC4282953.
  90. Penney KL, Sinnott JA, Tyekucheva S, Gerke T, Shui IM, Kraft P, Sesso HD, Freedman ML, Loda M, Mucci LA, Stampfer MJ. Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):255-60. PMID: 25371445; PMCID: PMC4294966 [Available on 01/01/16].
  91. Siddiqui MM, Wilson KM, Epstein MM, Rider JR, Martin NE, Stampfer MJ, Giovannucci EL, Mucci LA. Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol. 2014 Sep 20; 32(27):3033-8. PMID: 25002716; PMCID: PMC4162499.
  92. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Røder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokolorczyk D, Kluzniak W, Park J, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014 Oct; 46(10):1103-9. PMID: 25217961; PMCID: PMC4383163.
  93. Freedland S, Mucci L. Prostate cancer: Is active surveillance safe for obese patients? Nat Rev Urol. 2014 Sep; 11(9):489-90. PMID: 25112857.
    View in: PubMed
  94. Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men. Eur Urol. 2015 Feb; 67(2):191-4. PMID: 25107635; PMCID: PMC4318783 [Available on 02/01/16].
  95. Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, Loda M, Giovannucci E, Mucci LA, Olumi AF. 5a-Reductase inhibitors and risk of high-grade or lethal prostate cancer. JAMA Intern Med. 2014 Aug; 174(8):1301-7. PMID: 24887392; PMCID: PMC4122627.
  96. Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA. Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2027-31. PMID: 24925673; PMCID: PMC4184923.
  97. Preston MA, Riis AH, Ehrenstein V, Breau RH, Batista JL, Olumi AF, Mucci LA, Adami HO, Sørensen HT. Metformin use and prostate cancer risk. Eur Urol. 2014 Dec; 66(6):1012-20. PMID: 24857538.
    View in: PubMed
  98. Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA. Genetic variation across C-reactive protein and risk of prostate cancer. Prostate. 2014 Jul; 74(10):1034-42. PMID: 24844401; PMCID: PMC4063346.
  99. Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, Pukkala E, Christensen K, Adami HO, Holm NV, Nuttall E, Hansen S, Hartman M, Czene K, Harris JR, Kaprio J, Mucci LA. The heritability of prostate cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2303-10. PMID: 24812039; PMCID: PMC4221420.
  100. Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA. SPINK1 protein expression and prostate cancer progression. Clin Cancer Res. 2014 Sep 15; 20(18):4904-11. PMID: 24687926; PMCID: PMC4167171.
  101. Torfadottir JE, Stampfer MJ, Mucci LA, Giovannucci EL. RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2014 Apr; 106(4):dju018. PMID: 24685929.
    View in: PubMed
  102. Sharma J, Gray KP, Harshman LC, Evan C, Nakabayashi M, Fichorova R, Rider J, Mucci L, Kantoff PW, Sweeney CJ. Elevated IL-8, TNF-a, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival. Prostate. 2014 Jun; 74(8):820-8. PMID: 24668612.
    View in: PubMed
  103. Alemozaffar M, Sanda M, Yecies D, Mucci LA, Stampfer MJ, Kenfield SA. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study. Eur Urol. 2015 Mar; 67(3):432-8. PMID: 24582327; PMCID: PMC4128909.
  104. Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, Giovannucci E. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014 Feb; 106(2):djt430. PMID: 24463248; PMCID: PMC3952200.
  105. Park H, Schoenfeld J, Mucci L. Reply to 'Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer' by T. Kawada. Ann Oncol. 2014 Feb; 25(2):543-4. PMID: 24419238.
    View in: PubMed
  106. Shui IM, Lindström S, Kibel AS, Berndt SI, Campa D, Gerke T, Penney KL, Albanes D, Berg C, Bueno-de-Mesquita HB, Chanock S, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giles GG, Henderson B, Hoover R, Johansson M, Le Marchand L, Ma J, Navarro C, Overvad K, Schumacher FR, Severi G, Siddiq A, Stampfer M, Stevens VL, Travis RC, Trichopoulos D, Vineis P, Mucci LA, Yeager M, Giovannucci E, Kraft P. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol. 2014 Jun; 65(6):1069-75. PMID: 24411283; PMCID: PMC4006298.
  107. Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kantoff PW, Giovannucci EL, Loda M, Mucci LA. Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. J Natl Cancer Inst. 2013 Dec 18; 105(24):1881-90. PMID: 24292212; PMCID: PMC3866157.
  108. Mucci LA, Stampfer MJ. Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer. J Clin Oncol. 2014 Jan 01; 32(1):1-2. PMID: 24276780.
    View in: PubMed
  109. Russnes KM, Wilson KM, Epstein MM, Kasperzyk JL, Stampfer MJ, Kenfield SA, Smeland S, Blomhoff R, Giovannucci EL, Willett WC, Mucci LA. Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study. Int J Cancer. 2014 Mar 01; 134(5):1156-65. PMID: 23959920; PMCID: PMC4274735.
  110. Sharma J, Gray KP, Evan C, Nakabayashi M, Fichorova R, Rider J, Mucci L, Kantoff PW, Sweeney CJ. Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival. Prostate. 2014 Feb; 74(3):225-34. PMID: 24132762.
    View in: PubMed
  111. Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA. Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013 Dec; 22(12):2354-63. PMID: 24130224; PMCID: PMC3893763.
  112. Möller E, Adami HO, Mucci LA, Lundholm C, Bellocco R, Johansson JE, Grönberg H, Bälter K. Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden. Cancer Causes Control. 2013 Dec; 24(12):2143-55. PMID: 24048969.
    View in: PubMed
  113. Bismar TA, Alshalalfa M, Petersen LF, Teng LH, Gerke T, Bakkar A, Al-Mami A, Liu S, Dolph M, Mucci LA, Alhajj R. Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome. BJU Int. 2014 Feb; 113(2):309-19. PMID: 24006850.
    View in: PubMed
  114. Zu K, Martin NE, Fiorentino M, Flavin R, Lis RT, Sinnott JA, Finn S, Penney KL, Ma J, Fazli L, Gleave ME, Bismar TA, Stampfer MJ, Pollak MN, Loda M, Mucci LA, Giovannucci E. Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):1984-93. PMID: 23983239; PMCID: PMC3818474.
  115. Hogervorst JG, Fortner RT, Mucci LA, Tworoger SS, Eliassen AH, Hankinson SE, Wilson KM. Associations between dietary acrylamide intake and plasma sex hormone levels. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2024-36. PMID: 23983241; PMCID: PMC3827947.
  116. Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, Finn S, Giovannucci E, Sesso HD, Loda M, Mucci LA, Fiorentino M. Gleason grade progression is uncommon. Cancer Res. 2013 Aug 15; 73(16):5163-8. PMID: 23946472; PMCID: PMC3775342.
  117. Flynn-Evans EE, Mucci L, Stevens RG, Lockley SW. Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst. 2013 Sep 04; 105(17):1292-7. PMID: 23943864; PMCID: PMC3859215.
  118. Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov. 2013 Oct; 3(10):1130-41. PMID: 23779129; PMCID: PMC3797255.
  119. Robinson D, Garmo H, Bill-Axelson A, Mucci L, Holmberg L, Stattin P. Use of 5a-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study. BMJ. 2013 Jun 18; 346:f3406. PMID: 23778271; PMCID: PMC3685512.
  120. Wilson KM, Bälter K, Möller E, Adami HO, Andrén O, Andersson SO, Grönberg H, Mucci LA. Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study. Cancer Causes Control. 2013 Aug; 24(8):1575-81. PMID: 23702886.
    View in: PubMed
  121. Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, Czeisler CA, Launer L, Harris T, Stampfer MJ, Gudnason V, Lockley SW. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):872-9. PMID: 23652374; PMCID: PMC3652595.
  122. Möller E, Galeone C, Andersson TM, Bellocco R, Adami HO, Andrén O, Grönberg H, La Vecchia C, Mucci LA, Bälter K. Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case-control study. J Nutr Sci. 2013; 2:e15. PMID: 25191563; PMCID: PMC4153088.
  123. Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L. Consumption of fish products across the lifespan and prostate cancer risk. PLoS One. 2013; 8(4):e59799. PMID: 23613715; PMCID: PMC3629172.
  124. Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA. Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis. Ann Oncol. 2013 Jun; 24(6):1427-34. PMID: 23508824; PMCID: PMC3660083.
  125. Baena E, Shao Z, Linn DE, Glass K, Hamblen MJ, Fujiwara Y, Kim J, Nguyen M, Zhang X, Godinho FJ, Bronson RT, Mucci LA, Loda M, Yuan GC, Orkin SH, Li Z. ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes Dev. 2013 Mar 15; 27(6):683-98. PMID: 23512661; PMCID: PMC3613614.
  126. Margalit DN, Shui IM, Kasperzyk JL, Sesso HD, Martin NE, Nguyen PL, Kantoff PW, Rider JR, Mucci LA. Associations between single nucleotide polymorphisms (SNPs) in inflammation-related genes and quality of life after radiation therapy (RT) for prostate cancer. J Clin Oncol. 2013 Feb 20; 31(6_suppl):2. PMID: 28137148.
    View in: PubMed
  127. Cai C, Wang H, He HH, Chen S, He L, Ma F, Mucci L, Wang Q, Fiore C, Sowalsky AG, Loda M, Liu XS, Brown M, Balk SP, Yuan X. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. J Clin Invest. 2013 Mar; 123(3):1109-22. PMID: 23426182; PMCID: PMC3582143.
  128. Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA. A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res. 2013 Mar 15; 19(6):1612-9. PMID: 23382116; PMCID: PMC3602407.
  129. Preston MA, Harisinghani MG, Mucci L, Witiuk K, Breau RH. Diagnostic tests in urology: magnetic resonance imaging (MRI) for the staging of prostate cancer. BJU Int. 2013 Mar; 111(3):514-7. PMID: 23320634.
    View in: PubMed
  130. Gershman B, Shui IM, Stampfer M, Platz EA, Gann PH, Sesso HL, DuPre N, Giovannucci E, Mucci LA. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer. Eur Urol. 2014 Apr; 65(4):683-9. PMID: 23340241; PMCID: PMC3664134.
  131. Song Y, Chavarro JE, Cao Y, Qiu W, Mucci L, Sesso HD, Stampfer MJ, Giovannucci E, Pollak M, Liu S, Ma J. Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr. 2013 Feb; 143(2):189-96. PMID: 23256145; PMCID: PMC3542910.
  132. Penney KL, Li H, Mucci LA, Loda M, Sesso HD, Stampfer MJ, Ma J. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival. Prostate. 2013 May; 73(7):700-5. PMID: 23129481; PMCID: PMC3640488.
  133. Shui IM, Mucci LA, Wilson KM, Kraft P, Penney KL, Stampfer MJ, Giovannucci E. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):118-26. PMID: 23125333; PMCID: PMC3538912.
  134. Etzioni R, Mucci L, Chen S, Johansson JE, Fall K, Adami HO. Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Clin Cancer Res. 2012 Dec 15; 18(24):6742-7. PMID: 22927485; PMCID: PMC3711175.
  135. Epstein MM, Edgren G, Rider JR, Mucci LA, Adami HO. Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst. 2012 Sep 05; 104(17):1335-42. PMID: 22835388; PMCID: PMC3529593.
  136. Epstein MM, Kasperzyk JL, Mucci LA, Giovannucci E, Price A, Wolk A, Håkansson N, Fall K, Andersson SO, Andrén O. Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden. Am J Epidemiol. 2012 Aug 01; 176(3):240-52. PMID: 22781428; PMCID: PMC3491963.
  137. Rocca B, Santilli F, Pitocco D, Mucci L, Petrucci G, Vitacolonna E, Lattanzio S, Mattoscio D, Zaccardi F, Liani R, Vazzana N, Del Ponte A, Ferrante E, Martini F, Cardillo C, Morosetti R, Mirabella M, Ghirlanda G, Davì G, Patrono C. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. J Thromb Haemost. 2012 Jul; 10(7):1220-30. PMID: 22471290.
    View in: PubMed
  138. Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon AH, Suppan C, Flavin R, Sesso HD, Rider JR, Sweeney C, Stampfer MJ, Fiorentino M, Kantoff PW, Sanda MG, Giovannucci EL, Ding EL, Loda M, Mucci LA. The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012 Sep; 21(9):1497-509. PMID: 22736790; PMCID: PMC3671609.
  139. Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA. Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue. Cancer Causes Control. 2012 Aug; 23(8):1359-66. PMID: 22710747; PMCID: PMC3589913.
  140. Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, Mucci LA. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1002-11. PMID: 22564869; PMCID: PMC3392423.
  141. Torfadottir JE, Valdimarsdottir UA, Mucci L, Stampfer M, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Adami HO, Gudnason V, Steingrimsdottir L. Rye bread consumption in early life and reduced risk of advanced prostate cancer. Cancer Causes Control. 2012 Jun; 23(6):941-50. PMID: 22527172; PMCID: PMC3568695.
  142. Wilson KM, Giovannucci EL, Mucci LA. Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl. 2012 May; 14(3):365-74. PMID: 22504869; PMCID: PMC3720164.
  143. Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, Nimptsch K, Hollis BW, Dupre N, Platz EA, Stampfer MJ, Giovannucci E. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012 May 02; 104(9):690-9. PMID: 22499501; PMCID: PMC3341310.
  144. Möller E, Galeone C, Adami HO, Adolfsson J, Andersson TM, Bellocco R, Grönberg H, Mucci LA, Bälter K. The Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate in Sweden (CAPS) study. Public Health Nutr. 2012 Oct; 15(10):1897-908. PMID: 22463871.
    View in: PubMed
  145. Rudman SM, Gray KP, Kasperzyk J, Pitt M, Giovannucci E, Loda M, Mucci L, Sweeney C. Association of metabolic syndrome with reduced survival among men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):56. PMID: 28142922.
    View in: PubMed
  146. Sigurdardottir L, Valdimarsdottir UA, Mucci L, Fall K, Rider JR, Schernhammer ES, Czeisler CA, Launer L, Harris TB, Stampfer MJ, Gudnason V, Lockley SW. Insomnia among elderly men and risk of prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):78. PMID: 28142941.
    View in: PubMed
  147. Torfadottir JE, Valdimarsdottir UA, Mucci L, Stampfer MJ, Kasperzyk J, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinus H, Adami HO, Gudnason V, Steingrimsdottir L. Rye bread consumption in early life and reduced risk of advanced prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):79. PMID: 28142940.
    View in: PubMed
  148. Pettersson A, Kasperzyk JL, Kenfield SA, Richman EL, Chan JM, Willett WC, Stampfer MJ, Mucci LA, Giovannucci EL. Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):428-36. PMID: 22315365; PMCID: PMC3297731.
  149. Torfadottir JE, Steingrimsdottir L, Mucci L, Aspelund T, Kasperzyk JL, Olafsson O, Fall K, Tryggvadottir L, Harris TB, Launer L, Jonsson E, Tulinius H, Stampfer M, Adami HO, Gudnason V, Valdimarsdottir UA. Milk intake in early life and risk of advanced prostate cancer. Am J Epidemiol. 2012 Jan 15; 175(2):144-53. PMID: 22190107; PMCID: PMC3249408.
  150. Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, Cramer SD, Thomas MJ, Perry DL, Edwards IJ, Mucci LA, Sinnott JA, Loda MF, Sui G, Berquin IM, Chen YQ. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Carcinogenesis. 2012 Feb; 33(2):404-12. PMID: 22159221; PMCID: PMC3271270.
  151. Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, Ma J, Stampfer MJ, Mucci LA. Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):28-32. PMID: 22079732; PMCID: PMC3386602.
  152. Martin NE, Mucci LA, Loda M, Depinho RA. Prognostic determinants in prostate cancer. Cancer J. 2011 Nov-Dec; 17(6):429-37. PMID: 22157287; PMCID: PMC3240856.
  153. Dhillon PK, Penney KL, Schumacher F, Rider JR, Sesso HD, Pollak M, Fiorentino M, Finn S, Loda M, Rifai N, Mucci LA, Giovannucci E, Stampfer MJ, Ma J. Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2618-27. PMID: 21960694; PMCID: PMC3700351.
  154. Davidsson S, Fiorentino M, Andrén O, Fang F, Mucci LA, Varenhorst E, Fall K, Rider JR. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2011 Oct; 20(10):2280-7. PMID: 21953116; PMCID: PMC3671592.
  155. Kasperzyk JL, Shappley WV, Kenfield SA, Mucci LA, Kurth T, Ma J, Stampfer MJ, Sanda MG. Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study. J Urol. 2011 Nov; 186(5):1862-7. PMID: 21944095; PMCID: PMC3491639.
  156. Wilson KM, Giovannucci E, Stampfer MJ, Mucci LA. Dietary acrylamide and risk of prostate cancer. Int J Cancer. 2012 Jul 15; 131(2):479-87. PMID: 21866549; PMCID: PMC3320687.
  157. Barry M, Dhillon PK, Stampfer MJ, Perner S, Ma J, Giovannucci E, Kurth T, Mucci LA, Rubin MA. a-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study. Prostate. 2012 Feb; 72(3):301-6. PMID: 21713964; PMCID: PMC3267640.
  158. Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst. 2011 Jun 08; 103(11):876-84. PMID: 21586702; PMCID: PMC3110172.
  159. Shui IM, Stark JR, Penney KL, Schumacher FR, Epstein MM, Pitt MJ, Stampfer MJ, Tamimi RM, Lindstrom S, Sesso HD, Fall K, Ma J, Kraft P, Giovannucci E, Mucci LA. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality. Prostate. 2012 Feb 01; 72(2):209-16. PMID: 21563195; PMCID: PMC3175021.
  160. Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, Andersson SO, Martin N, Kantoff PW, Johansson JE, Adami HO, Rubin MA, Loda M, Golub TR, Andrén O, Stampfer MJ, Mucci LA. mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol. 2011 Jun 10; 29(17):2391-6. PMID: 21537050; PMCID: PMC3107753.
  161. Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol. 2011 Jun 10; 29(17):2378-85. PMID: 21537045; PMCID: PMC3107752.
  162. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011 Apr 06; 6(4):e18625. PMID: 21494639; PMCID: PMC3071841.
  163. Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, Niu Y, Cheong JK, Hunter DJ, Stampfer MJ, Hsu SI. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels. Carcinogenesis. 2011 Jun; 32(6):853-9. PMID: 21421545; PMCID: PMC3106437.
  164. Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Labrot ES, Wu X, Lis R, Hoshida Y, Hiller D, Hu B, Jiang S, Zheng H, Stegh AH, Scott KL, Signoretti S, Bardeesy N, Wang YA, Hill DE, Golub TR, Stampfer MJ, Wong WH, Loda M, Mucci L, Chin L, DePinho RA. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature. 2011 Feb 10; 470(7333):269-73. PMID: 21289624; PMCID: PMC3753179.
  165. Epstein MM, Kasperzyk JL, Andrén O, Giovannucci EL, Wolk A, Håkansson N, Andersson SO, Johansson JE, Fall K, Mucci LA. Dietary zinc and prostate cancer survival in a Swedish cohort. Am J Clin Nutr. 2011 Mar; 93(3):586-93. PMID: 21228268; PMCID: PMC3041600.
  166. Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, Oh WK, Kantoff PW, Hahn WC, Freedman ML. Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet. 2010 Nov 11; 6(11):e1001204. PMID: 21085629; PMCID: PMC2978684.
  167. Penney KL, Pyne S, Schumacher FR, Sinnott JA, Mucci LA, Kraft PL, Ma J, Oh WK, Kurth T, Kantoff PW, Giovannucci EL, Stampfer MJ, Hunter DJ, Freedman ML. Genome-wide association study of prostate cancer mortality. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2869-76. PMID: 20978177; PMCID: PMC3197738.
  168. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010 Nov; 92(5):1223-33. PMID: 20844069.
    View in: PubMed
  169. Wilson KM, Mucci LA, Rosner BA, Willett WC. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2503-15. PMID: 20693310; PMCID: PMC2952046.
  170. Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol. 2010 Sep 01; 28(25):3958-64. PMID: 20679621; PMCID: PMC2940394.
  171. Meyer MS, Penney KL, Stark JR, Schumacher FR, Sesso HD, Loda M, Fiorentino M, Finn S, Flavin RJ, Kurth T, Price AL, Giovannucci EL, Fall K, Stampfer MJ, Ma J, Mucci LA. Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis. 2010 Sep; 31(9):1597-603. PMID: 20576793; PMCID: PMC2930803.
  172. Fang F, Valdimarsdóttir U, Mucci L, Sparén P, Ye W, Fall K. Hospitalization for osteoarthritis and prostate cancer specific mortality among Swedish men with prostate cancer. Cancer Epidemiol. 2010 Oct; 34(5):644-7. PMID: 20561833.
    View in: PubMed
  173. Meyer MS, Mucci LA, Andersson SO, Andrén O, Johansson JE, Tretli S, Adami HO. Homogeneous prostate cancer mortality in the Nordic countries over four decades. Eur Urol. 2010 Sep; 58(3):427-32. PMID: 20541313; PMCID: PMC2936655.
  174. Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, Tjønneland A, Albanes D, Calle EE, Giovannucci E, Crawford ED, Haiman CA, Kraft P, Willett WC, Thun MJ, Le Marchand L, Kaaks R, Feigelson HS, Bueno-de-Mesquita HB, Palli D, Riboli E, Lund E, Amiano P, Andriole G, Dunning AM, Trichopoulos D, Stampfer MJ, Key TJ, Ma J. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet. 2010 Aug 01; 19(15):3089-101. PMID: 20484221; PMCID: PMC2901143.
  175. Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T, Mucci LA, Hunter DJ, Kantoff PW, Stampfer MJ, Ma J. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila). 2010 May; 3(5):604-10. PMID: 20424130; PMCID: PMC2865569.
  176. Fiorentino M, Judson G, Penney K, Flavin R, Stark J, Fiore C, Fall K, Martin N, Ma J, Sinnott J, Giovannucci E, Stampfer M, Sesso HD, Kantoff PW, Finn S, Loda M, Mucci L. Immunohistochemical expression of BRCA1 and lethal prostate cancer. Cancer Res. 2010 Apr 15; 70(8):3136-9. PMID: 20388772; PMCID: PMC3049266.
  177. Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y, Perner S, Adami HO, Fall K, Mucci LA, Kantoff PW, Stampfer M, Andersson SO, Varenhorst E, Johansson JE, Gerstein MB, Golub TR, Rubin MA, Andrén O. Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics. 2010 Mar 16; 3:8. PMID: 20233430; PMCID: PMC2855514.
  178. Fang F, Keating NL, Mucci LA, Adami HO, Stampfer MJ, Valdimarsdóttir U, Fall K. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst. 2010 Mar 03; 102(5):307-14. PMID: 20124521.
    View in: PubMed
  179. Mucci LA, Stark JR, Pollak MN, Li H, Kurth T, Stampfer MJ, Ma J. Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev. 2010 Feb; 19(2):484-91. PMID: 20142246; PMCID: PMC2820127.
  180. Vikström AC, Wilson KM, Paulsson B, Athanassiadis I, Grönberg H, Adami HO, Adolfsson J, Mucci LA, Bälter K, Törnqvist M. Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobin-adducts and questionnaire data. Food Chem Toxicol. 2010 Mar; 48(3):820-4. PMID: 20034532.
    View in: PubMed
  181. Fall K, Fang F, Mucci LA, Ye W, Andrén O, Johansson JE, Andersson SO, Sparén P, Klein G, Stampfer M, Adami HO, Valdimarsdóttir U. Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med. 2009 Dec; 6(12):e1000197. PMID: 20016838; PMCID: PMC2784954.
  182. Arora M, Weuve J, Fall K, Pedersen NL, Mucci LA. An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study. Am J Epidemiol. 2010 Jan 15; 171(2):253-9. PMID: 19969528; PMCID: PMC2878098.
  183. Li H, Stampfer MJ, Mucci L, Rifai N, Qiu W, Kurth T, Ma J. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem. 2010 Jan; 56(1):34-43. PMID: 19910504; PMCID: PMC2858593.
  184. Mucci LA, Powolny A, Giovannucci E, Liao Z, Kenfield SA, Shen R, Stampfer MJ, Clinton SK. Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol. 2009 Nov 20; 27(33):5627-33. PMID: 19858401; PMCID: PMC2792955.
  185. Stark JR, Mucci L, Rothman KJ, Adami HO. Screening for prostate cancer remains controversial. BMJ. 2009 Sep 24; 339:b3601. PMID: 19778971.
    View in: PubMed
  186. Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst. 2009 Oct 21; 101(20):1406-11. PMID: 19741211; PMCID: PMC2765259.
  187. Mucci LA, Stark JR, Figg WD, Schumacher F, Li H, Abe M, Hennessy K, Stampfer MJ, Gaziano JM, Ma J, Kantoff PW. Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study. Int J Cancer. 2009 Sep 01; 125(5):1143-6. PMID: 19431146; PMCID: PMC2838373.
  188. Mucci LA, Hsieh CC, Williams PL, Arora M, Adami HO, de Faire U, Douglass CW, Pedersen NL. Do genetic factors explain the association between poor oral health and cardiovascular disease? A prospective study among Swedish twins. Am J Epidemiol. 2009 Sep 01; 170(5):615-21. PMID: 19648170; PMCID: PMC2732988.
  189. Kasperzyk JL, Fall K, Mucci LA, Håkansson N, Wolk A, Johansson JE, Andersson SO, Andrén O. One-carbon metabolism-related nutrients and prostate cancer survival. Am J Clin Nutr. 2009 Sep; 90(3):561-9. PMID: 19571228; PMCID: PMC2728642.
  190. Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer MJ, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res. 2009 Jul 01; 69(13):5568-74. PMID: 19549893; PMCID: PMC2884104.
  191. Stark JR, Li H, Kraft P, Kurth T, Giovannucci EL, Stampfer MJ, Ma J, Mucci LA. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer. 2009 Jun 01; 124(11):2683-9. PMID: 19189403; PMCID: PMC2667697.
  192. Stark JR, Wiklund F, Grönberg H, Schumacher F, Sinnott JA, Stampfer MJ, Mucci LA, Kraft P. Toll-like receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1859-63. PMID: 19505919; PMCID: PMC2833418.
  193. Wilson KM, Bälter K, Adami HO, Grönberg H, Vikström AC, Paulsson B, Törnqvist M, Mucci LA. Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study. Int J Cancer. 2009 May 15; 124(10):2384-90. PMID: 19142870; PMCID: PMC2905318.
  194. Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS, Ma J, Fiorentino M, Kurth T, Loda M, Giovannucci EL, Rubin MA, Mucci LA. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol. 2009 Jul 20; 27(21):3459-64. PMID: 19433685; PMCID: PMC2717753.
  195. Mucci LA, Adami HO. The plight of the potato: is dietary acrylamide a risk factor for human cancer? J Natl Cancer Inst. 2009 May 06; 101(9):618-21. PMID: 19401554.
    View in: PubMed
  196. Penney KL, Salinas CA, Pomerantz M, Schumacher FR, Beckwith CA, Lee GS, Oh WK, Sartor O, Ostrander EA, Kurth T, Ma J, Mucci L, Stanford JL, Kantoff PW, Hunter DJ, Stampfer MJ, Freedman ML. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clin Cancer Res. 2009 May 01; 15(9):3223-30. PMID: 19366828; PMCID: PMC2878092.
  197. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E, Fiore C, Xie W, Kung AL, Febbo PG, Subramanian A, Mucci L, Ma J, Signoretti S, Stampfer M, Hahn WC, Finn S, Loda M. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst. 2009 Apr 01; 101(7):519-32. PMID: 19318631; PMCID: PMC2664091.
  198. Liu C, Wang XD, Mucci L, Gaziano JM, Zhang SM. Modulation of lung molecular biomarkers by beta-carotene in the Physicians' Health Study. Cancer. 2009 Mar 01; 115(5):1049-58. PMID: 19142877; PMCID: PMC2649969.
  199. Wilson KM, Mucci LA, Cho E, Hunter DJ, Chen WY, Willett WC. Dietary acrylamide intake and risk of premenopausal breast cancer. Am J Epidemiol. 2009 Apr 15; 169(8):954-61. PMID: 19224978; PMCID: PMC2727226.
  200. Dhillon PK, Barry M, Stampfer MJ, Perner S, Fiorentino M, Fornari A, Ma J, Fleet J, Kurth T, Rubin MA, Mucci LA. Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev. 2009 Feb; 18(2):595-600. PMID: 19155438; PMCID: PMC2692093.
  201. Andrèn O, Garmo H, Mucci L, Andersson SO, Johansson JE, Fall K. Incidence and mortality of incidental prostate cancer: a Swedish register-based study. Br J Cancer. 2009 Jan 13; 100(1):170-3. PMID: 19088721; PMCID: PMC2634678.
  202. Holmberg L, Adolfsson J, Mucci L, Garmo H, Adami HO, Möller H, Johansson JE, Stampfer M. Season of diagnosis and prognosis in breast and prostate cancer. Cancer Causes Control. 2009 Jul; 20(5):663-70. PMID: 19067189.
    View in: PubMed
  203. Fiorentino M, Zadra G, Palescandolo E, Fedele G, Bailey D, Fiore C, Nguyen PL, Migita T, Zamponi R, Di Vizio D, Priolo C, Sharma C, Xie W, Hemler ME, Mucci L, Giovannucci E, Finn S, Loda M. Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab Invest. 2008 Dec; 88(12):1340-8. PMID: 18838960; PMCID: PMC3223737.
  204. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM, Pollak M, Stampfer MJ. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008 Nov; 9(11):1039-47. PMID: 18835745; PMCID: PMC2651222.
  205. Jesser C, Mucci L, Farmer D, Moon C, Li H, Gaziano JM, Stampfer M, Ma J, Kantoff P. Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels. Br J Cancer. 2008 Nov 18; 99(10):1743-7. PMID: 18827812; PMCID: PMC2584945.
  206. Fall K, Stark JR, Mucci LA, Chan J, Stampfer MJ, Kurth T, Febbo PG, Kantoff P, Ma J. No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk. Prostate. 2008 Sep 15; 68(13):1416-20. PMID: 18615538; PMCID: PMC2958090.
  207. Cnattingius S, Eloranta S, Adami HO, Axelsson O, Dickman PW, Hsieh CC, Mucci LA, Trichopoulos D, Lambe M, Johansson AL. Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2344-9. PMID: 18768502; PMCID: PMC2643070.
  208. Kakizoe T, Mucci LA, Albertsen PC, Droller MJ. Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease. Scand J Urol Nephrol Suppl. 2008 Sep; (218):191-212. PMID: 18815934.
    View in: PubMed
  209. Mucci LA, Wilson KM. Acrylamide intake through diet and human cancer risk. J Agric Food Chem. 2008 Aug 13; 56(15):6013-9. PMID: 18624443.
    View in: PubMed
  210. Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein A, Holmberg L, Huang W, Kantoff PW, Kim R, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort. Cancer Epidemiol Biomarkers Prev. 2008 Jul; 17(7):1682-8. PMID: 18583469; PMCID: PMC2536630.
  211. Baik I, Lambe M, Liu Q, Chie L, Cnattingius S, Mucci LA, Riman T, Ekbom A, Adami HO, Hsieh CC. Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort. Cancer Causes Control. 2008 Dec; 19(10):1131-7. PMID: 18509730; PMCID: PMC3221393.
  212. Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andrén O, Johnson LA, Tang J, Adami HO, Calza S, Chinnaiyan AM, Rhodes D, Tomlins S, Fall K, Mucci LA, Kantoff PW, Stampfer MJ, Andersson SO, Varenhorst E, Johansson JE, Brown M, Golub TR, Rubin MA. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst. 2008 Jun 04; 100(11):815-25. PMID: 18505969; PMCID: PMC3073404.
  213. Mucci LA, Spiegelman D. Vitamin D and prostate cancer risk--a less sunny outlook? J Natl Cancer Inst. 2008 Jun 04; 100(11):759-61. PMID: 18505963.
    View in: PubMed
  214. Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein AS, Holmberg L, Huang W, Kantoff PW, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Cancer Epidemiol Biomarkers Prev. 2008 Jan; 17(1):249-51. PMID: 18199732.
    View in: PubMed
  215. Baik I, Lambe M, Liu Q, Cnattingius S, Mucci LA, Riman T, Ekbom A, Adami HO, Hsieh CC. Gender of offspring and maternal risk of invasive epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2314-20. PMID: 18006920.
    View in: PubMed
  216. McIntyre MH, Kantoff PW, Stampfer MJ, Mucci LA, Parslow D, Li H, Gaziano JM, Abe M, Ma J. Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2233-6. PMID: 18006911.
    View in: PubMed
  217. Bakaysa SL, Mucci LA, Slagboom PE, Boomsma DI, McClearn GE, Johansson B, Pedersen NL. Telomere length predicts survival independent of genetic influences. Aging Cell. 2007 Dec; 6(6):769-74. PMID: 17925004.
    View in: PubMed
  218. Sarzani R, Marcucci P, Salvi F, Bordicchia M, Espinosa E, Mucci L, Lorenzetti B, Minardi D, Muzzonigro G, Dessì-Fulgheri P, Rappelli A. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int J Obes (Lond). 2008 Feb; 32(2):259-67. PMID: 17878892.
    View in: PubMed
  219. Mucci LA, Dickman PW, Lambe M, Adami HO, Trichopoulos D, Riman T, Hsieh CC, Cnattingius S. Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort. Cancer Epidemiol Biomarkers Prev. 2007 Sep; 16(9):1828-32. PMID: 17855701; PMCID: PMC2646123.
  220. Andrén O, Fall K, Andersson SO, Rubin MA, Bismar TA, Karlsson M, Johansson JE, Mucci LA. MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden. Br J Cancer. 2007 Sep 17; 97(6):730-4. PMID: 17726465; PMCID: PMC2360377.
  221. Lagiou P, Sandin S, Weiderpass E, Lagiou A, Mucci L, Trichopoulos D, Adami HO. Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med. 2007 Apr; 261(4):366-74. PMID: 17391111.
    View in: PubMed
  222. Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007 Mar; 4(3):e103. PMID: 17388667; PMCID: PMC1831738.
  223. Demichelis F, Fall K, Perner S, Andrén O, Schmidt F, Setlur SR, Hoshida Y, Mosquera JM, Pawitan Y, Lee C, Adami HO, Mucci LA, Kantoff PW, Andersson SO, Chinnaiyan AM, Johansson JE, Rubin MA. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene. 2007 Jul 05; 26(31):4596-9. PMID: 17237811.
    View in: PubMed
  224. Mucci LA, Dickman PW, Lambe M, Adami HO, Trichopoulos D, Riman T, Hsieh CC, Cnattingius S. Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort. CEBP. 2007; In press.
  225. Mucci LA, Signorello L, Adami HO. Prostate Cancer. Adami HO, Hunter D, Trichopoulos D, editors. Cancer epidemiology: causes and occurrence of cancer. 2007; In press.
  226. Brennan P, Mucci LA, Adami HO. Oral and pharyngeal cancer. Adami HO, Hunter D, Trichopoulos D, editors. Cancer epidemiology: causes and occurrence of cancer. 2007; In press.
  227. Mucci LA, Wood PA, Cohen B, Clements KM, Brawarsky P, Brooks DR. Validity of self-reported health plan information in a population-based health survey. J Public Health Manag Pract. 2006 Nov-Dec; 12(6):570-7. PMID: 17041306.
    View in: PubMed
  228. Hunt H, Valdimarsdottir U, Mucci L, Kreicbergs U, Steineck G. When death appears best for the child with severe malignancy: a nationwide parental follow-up. Palliat Med. 2006 Sep; 20(6):567-77. PMID: 17060249.
    View in: PubMed
  229. Lagiou P, Trichopoulos D, Sandin S, Lagiou A, Mucci L, Wolk A, Weiderpass E, Adami HO. Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr. 2006 Aug; 96(2):384-92. PMID: 16923235.
    View in: PubMed
  230. Clements KM, Cohen BB, Brawarsky P, Brooks DR, Mucci LA, Wood PA. Identifying Health Maintenance Organization membership through self-report of health plan name: ascertainment and reliability. J Public Health Manag Pract. 2006 May-Jun; 12(3):278-87. PMID: 16614564.
    View in: PubMed
  231. Lagerros YT, Mucci LA, Bellocco R, Nyrén O, Bälter O, Bälter KA. Validity and reliability of self-reported total energy expenditure using a novel instrument. Eur J Epidemiol. 2006; 21(3):227-36. PMID: 16547838.
    View in: PubMed
  232. Mucci LA, Adami HO, Wolk A. Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer. 2006 Jan 01; 118(1):169-73. PMID: 16003738.
    View in: PubMed
  233. Wilson KM, Rimm EB, Thompson KM, Mucci LA. Dietary acrylamide and cancer risk in humans: A review. J Consum Protection Food Safety. 2006; In press.
  234. Lagiou P, Sandin S, Weiderpass E, Mucci LA, Wolk A, Adami HO, Trichopoulos D. Mediterranean dietary pattern and mortality among young women - a cohort study in Sweden. Brit J Nut. 2006; 96:384-392.
  235. Trolle-Lagerros Y, Mucci LA, Kumle M, Braaten T, Weiderpass E, Hsieh CC, Sandin S, Lagiou P, Trichopoulos D, Lund E, Adami HO. Physical activity as a major determinant of mortality in women: a prospective study in Norway and Sweden. Epidemiology. 2005; In press.
  236. Trolle-Lagerros Y, Mucci LA, Kumle M, Braaten T, Weiderpass E, Hsieh CC, Sandin S, Lagiou P, Trichopoulos D, Lund E, Adami HO. Physical activity as a determinant of mortality in women. Epidemiology. 2005 Nov; 16(6):780-5. PMID: 16222168.
    View in: PubMed
  237. Mucci LA, Björkman L, Douglass CW, Pedersen NL. Environmental and heritable factors in the etiology of oral diseases--a population-based study of Swedish twins. J Dent Res. 2005 Sep; 84(9):800-5. PMID: 16109987.
    View in: PubMed
  238. Bradbury BD, Brooks DR, Brawarsky P, Mucci LA. Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS). Prev Med. 2005 Jul; 41(1):303-11. PMID: 15917026.
    View in: PubMed
  239. Rubin MA, Bismar TA, Andrén O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1424-32. PMID: 15941951.
    View in: PubMed
  240. Mucci LA, Sandin S, Bälter K, Adami HO, Magnusson C, Weiderpass E. Acrylamide intake and breast cancer risk in Swedish women. JAMA. 2005 Mar 16; 293(11):1326-7. PMID: 15769965.
    View in: PubMed
  241. Rubin MA, Bismar TA, Andrén O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE. Decreased Alpha-Methylacyl CoA racemase Expression in Localized Prostate Cancer is Associated with an Increased Rate of Biochemical Recurrence and Cancer Specific Death. Cancer Epidemiol Biomarker Prev. 2005; 14(6):1424-32.
  242. Margolis KL, Mucci L, Braaten T, Kumle M, Trolle Lagerros Y, Adami HO, Lund E, Weiderpass E. Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women's Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):27-32. PMID: 15668472.
    View in: PubMed
  243. Badovinac RL, Morgan KE, Lefevre J, Wadhawan S, Mucci L, Schoeff L, Douglass CW. Risk assessment criteria applied to a screening exam: implications for improving the efficiency of a sealant program. J Public Health Dent. 2005; 65(4):203-8. PMID: 16468461.
    View in: PubMed
  244. Mucci LA, Adami HO. The Role of Epidemiology in Understanding the Relationship Between Dietary Acrylamide and Cancer Risk in Humans. Chemistry and Safety of Acrylamide in Food. 2005; 39-48.
  245. Mucci LA, Adami HO. The role of epidemiology in understanding the relationship between dietary acrylamide and cancer risk in humans. Adv Exp Med Biol. 2005; 561:39-47. PMID: 16438287.
    View in: PubMed
  246. Mucci LA, Rimm E, Thompson K. Re: Potential Regulatory Action Exempting from the Proposition 65 Warning Requirements, Exposures from Chemicals that form from Natural Constituents in Food During Cooking or Heat Processing [Letter]. Response to the Office of Environmental Health Hazard Assessment, State of California. 2005.
  247. Brooks DR, Mucci LA, Hatch EE, Cnattingius S. Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births. Cancer Causes Control. 2004 Dec; 15(10):997-1005. PMID: 15801484.
    View in: PubMed
  248. Mucci LA, Lagiou P, Hsieh CC, Tamimi R, Hellerstein S, Vatten L, Adami HO, Cnattingius S, Trichopoulos D. A prospective study of pregravid oral contraceptive use in relation to fetal growth. BJOG. 2004 Sep; 111(9):989-95. PMID: 15327615.
    View in: PubMed
  249. Mucci LA, Granath F, Cnattingius S. Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children. Cancer Epidemiol Biomarkers Prev. 2004 Sep; 13(9):1528-33. PMID: 15342456.
    View in: PubMed
  250. Mucci LA, Lindblad P, Steineck G, Adami HO. Dietary acrylamide and risk of renal cell cancer. Int J Cancer. 2004 May 01; 109(5):774-6. PMID: 14999788.
    View in: PubMed
  251. Lagiou P, Mucci L, Tamimi R, Kuper H, Lagiou A, Hsieh CC, Trichopoulos D. Micronutrient intake during pregnancy in relation to birth size. Eur J Nutr. 2005 Feb; 44(1):52-9. PMID: 15309438.
    View in: PubMed
  252. Mucci LA, Hsieh CC, Williams PL, Dickman PW, Björkman L, Pedersen NL. Birth order, sibship size, and housing density in relation to tooth loss and periodontal disease: a cohort study among Swedish twins. Am J Epidemiol. 2004 Mar 01; 159(5):499-506. PMID: 14977646.
    View in: PubMed
  253. Lagiou P, Tamimi RM, Mucci LA, Adami HO, Hsieh CC, Trichopoulos D. Diet during pregnancy in relation to maternal weight gain and birth size. Eur J Clin Nutr. 2004 Feb; 58(2):231-7. PMID: 14749741.
    View in: PubMed
  254. Brawarsky P, Brooks DR, Mucci LA, Wood PA. Effect of physician recommendation and patient adherence on rates of colorectal cancer testing. Cancer Detect Prev. 2004; 28(4):260-8. PMID: 15350629.
    View in: PubMed
  255. Tamimi R, Lagiou P, Vatten LJ, Mucci L, Trichopoulos D, Hellerstein S, Ekbom A, Adami HO, Hsieh CC. Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev. 2003 Jul; 12(7):647-50. PMID: 12869405.
    View in: PubMed
  256. Tamimi RM, Lagiou P, Mucci LA, Hsieh CC, Adami HO, Trichopoulos D. Average energy intake among pregnant women carrying a boy compared with a girl. BMJ. 2003 Jun 07; 326(7401):1245-6. PMID: 12791740; PMCID: PMC161555.
  257. Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K. Dietary acrylamide and cancer risk: additional data on coffee. Br J Cancer. 2003; 89(4):775-6.
  258. Brawarsky P, Brooks DR, Mucci LA. Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med. 2003 Jun; 36(6):659-68. PMID: 12744908.
    View in: PubMed
  259. Mucci LA, Lagiou P, Tamimi RM, Hsieh CC, Adami HO, Trichopoulos D. Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes Control. 2003 May; 14(4):311-8. PMID: 12846361.
    View in: PubMed
  260. Lagiou P, Hsieh CC, Trichopoulos D, Xu B, Wuu J, Mucci L, Tamimi R, Adami HO, Cnattingius S. Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol. 2003 Apr; 32(2):193-8. PMID: 12714535.
    View in: PubMed
  261. Lagiou P, Tamimi R, Mucci LA, Trichopoulos D, Adami HO, Hsieh CC. Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: a prospective study. Obstet Gynecol. 2003 Apr; 101(4):639-44. PMID: 12681864.
    View in: PubMed
  262. Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K. Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer. 2003 Jan 13; 88(1):84-9. PMID: 12556964; PMCID: PMC2376776.
  263. Tamimi RM, Trichopoulos D, Lagiou P, Mucci LA, Adami HO, Hsieh CC. Authors Reply: Average energy intake is higher among pregnant women carrying a boy rather than a girl [Letter]. BMJ. 2003; (327):622.
  264. Mucci LA. The Epidemiology of Periodontal Disease in the Swedish Twin Registry. 2002.
  265. Lagiou P, Tamimi R, Lagiou A, Mucci L, Trichopoulos D. Is epidemiology implicating extremely low frequency electric and magnetic fields in childhood leukemia? Environ Health Prev Med. 2002 May; 7(2):33-9. PMID: 21432262; PMCID: PMC2723397.
  266. Lagiou P, Tamimi R, Lagiou A, Mucci L, Trichopoulos D. Is epidemiology implicating extremely low frequency electric and magnetic fields in childhood leukemia?. Env Health Prev Med. 2002; 7:33-9.
  267. Mucci LA, Adami HO. Oral and pharyngeal cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Cancer epidemiology: causes and occurrence of cancer. 2002; 115-136.
  268. Kuper H, Ye W, Broomé U, Romelsjö A, Mucci LA, Ekbom A, Adami HO, Trichopoulos D, Nyrén O. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology. 2001 Oct; 34(4 Pt 1):714-8. PMID: 11584367.
    View in: PubMed
  269. Boffetta P, Ye W, Adami HO, Mucci LA, Nyrén O. Risk of cancers of the lung, head and neck in patients hospitalized for alcoholism in Sweden. Br J Cancer. 2001 Sep 01; 85(5):678-82. PMID: 11531251; PMCID: PMC2364115.
  270. Orner MB, Meehan T, Brooks DR, Mucci LA, McGuire JF. Support for condom availability and needle exchange programs among Massachusetts adults, 1997. AIDS Educ Prev. 2001 Aug; 13(4):365-76. PMID: 11565595.
    View in: PubMed
  271. Benson M, Brooks DR, Meehan T, Mucci LA, McGuire J. Support for needle exchange and condom distribution programs in Massachusetts, 1997. AIDS Educ Prev. 2001; 13:365-76.
  272. Silverman JG, Raj A, Mucci LA, Hathaway JE. Dating violence against adolescent girls and associated substance use, unhealthy weight control, sexual risk behavior, pregnancy, and suicidality. JAMA. 2001 Aug 01; 286(5):572-9. PMID: 11476659.
    View in: PubMed
  273. Weiderpass E, Ye W, Mucci LA, Nyrén O, Trichopoulos D, Vainio H, Adami HO. Alcoholism and risk for endometrial cancer. Int J Cancer. 2001 Jul 15; 93(2):299-301. PMID: 11410881.
    View in: PubMed
  274. Tamimi R, Mucci LA, Spanos E, Lagiou A, Benetou V, Trichopoulos D. Testosterone and oestradiol in relation to tobacco smoking, body mass index, energy consumption and nutrient intake among adult men. Eur J Cancer Prev. 2001 Jun; 10(3):275-80. PMID: 11432716.
    View in: PubMed
  275. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med. 2001 Jun; 249(6):477-93. PMID: 11422654.
    View in: PubMed
  276. Mucci LA, Brooks DR. Lower use of dental services among long term cigarette smokers. J Epidemiol Community Health. 2001 Jun; 55(6):389-93. PMID: 11350994; PMCID: PMC1731911.
  277. Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, Trichopoulos D. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int. 2001 Jun; 87(9):814-20. PMID: 11412218.
    View in: PubMed
  278. Demissie S, Green RC, Mucci L, Tziavas S, Martelli K, Bang K, Coons L, Bourque S, Buchillon D, Johnson K, Smith T, Sharrow N, Lautenschlager N, Friedland R, Cupples LA, Farrer LA. Reliability of information collected by proxy in family studies of Alzheimer's disease. Neuroepidemiology. 2001 May; 20(2):105-11. PMID: 11359077.
    View in: PubMed
  279. Mucci LA, Kuper HE, Tamimi R, Lagiou P, Spanos E, Trichopoulos D. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG. 2001 Mar; 108(3):291-4. PMID: 11281471.
    View in: PubMed
  280. Brooks DR, Mucci LA. Support for smoke-free restaurants among Massachusetts adults, 1992-1999. Am J Public Health. 2001 Feb; 91(2):300-3. PMID: 11211644; PMCID: PMC1446536.
  281. Lagiou A, Trichopoulos D, Tzonou A, Lagiou P, Mucci L. Are there age-dependent effects of diet on prostate cancer risk? Soz Praventivmed. 2001; 46(5):329-34. PMID: 11759340.
    View in: PubMed
  282. Kuper H, Lagiou P, Mucci LA, Tamimi R, Benetou V, Trichopoulos D. Risk factors for cholangiocarcinoma in a low risk Caucasian population. Soz Praventivmed. 2001; 46(3):182-5. PMID: 11565447.
    View in: PubMed
  283. Lagiou A, Trichopoulos D, Tzonou A, Lagiou P, Mucci L. Are there age-dependent effects of diet on prostate cancer risk?. Soc Prev Med. 2001; 46(5):329-34.
  284. Kuper H, Mantzoros C, Lagiou P, Tzonou A, Tamimi R, Mucci L, Benetou V, Spanos E, Stuver SO, Trichopoulos D. Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men. Oncology. 2001; 60(4):355-60. PMID: 11408804.
    View in: PubMed
  285. Hathaway JE, Mucci LA, Silverman JG, Brooks DR, Mathews R, Pavlos CA. Health status and health care use of Massachusetts women reporting partner abuse. Am J Prev Med. 2000 Nov; 19(4):302-7. PMID: 11064235.
    View in: PubMed
  286. Kuper H, Hsieh C, Stuver SO, Mucci LA, Tzonou A, Zavitsanos X, Lagiou P, Trichopoulos D. Birth order, as a proxy for age at infection, in the etiology of hepatocellular carcinoma. Epidemiology. 2000 Nov; 11(6):680-3. PMID: 11055629.
    View in: PubMed
  287. Petridou E, Giokas G, Kuper H, Mucci LA, Trichopoulos D. Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece. Br J Cancer. 2000 Nov; 83(9):1234-7. PMID: 11027439; PMCID: PMC2363586.
  288. Kuper HE, Mucci LA, Trichopoulos D. Coffee, pancreatic cancer and the question of causation. J Epidemiol Community Health. 2000 Sep; 54(9):650-1. PMID: 10942440; PMCID: PMC1731751.
  289. Hathaway J, Silverman J, Aynalem G, Mucci LA, Brooks D. Utilization of medical care, police assistance, and restraining orders by women reporting intimate partner violence-Massachusetts, 1996-199. MMWR. 2000; 49:485-8 [Reprinted in JAMA 2000].
  290. Signorello LB, Kuper H, Lagiou P, Wuu J, Mucci LA, Trichopoulos D, Adami HO. Lifestyle factors and insulin-like growth factor 1 levels among elderly men. Eur J Cancer Prev. 2000 Jun; 9(3):173-8. PMID: 10954256.
    View in: PubMed
  291. Kuper H, Tzonou A, Lagiou P, Mucci LA, Trichopoulos D, Stuver SO, Trichopoulou A. Diet and hepatocellular carcinoma: a case-control study in Greece. Nutr Cancer. 2000; 38(1):6-12. PMID: 11341045.
    View in: PubMed
  292. Di Marco G, De Simone G, Cionci M, D'Ercole A, Mantini G, Mucci L, Boschetti N. [Epidemiological study of arterial hypertension in the population of Vasto]. Boll Soc Ital Cardiol. 1980; 25(3):245-52. PMID: 7284129.
    View in: PubMed
  293. Kunos G, Hoffman B, Kwok YN, Kan WH, Mucci L. Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle. Nature. 1979 Mar 15; 278(5701):254-6. PMID: 218110.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu). HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mucci's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_